Tialin is licensed for the treatment of dysentery, colitis, ileitis, pneumonia and pleuropneumonia in pigs. It is also suitable for the treatment and metaphylaxis of chronic respiratory disease and infectious synovitis in chickens and infectious sinusitis and airsacculitis in turkeys. Withdrawal times range from zero in eggs to two - six days in meat and offal.
The product is available in two strengths: 25% (250 mg/ml) and 12.5% (125 mg/ml). It can be bought in five and one litre bottles with a shelf life of two years or three months once opened.
Dechra Brand Manager Emma Jennings said: "Any of these diseases could have a widespread effect on a herd or flock of any size so it is vital that veterinary professionals have access to a treatment such as Tialin to offer farmers.
"Its short withdrawal times and long shelf life makes it a cost effective and valuable tool for vets and farmers in their treatments of these diseases. All the products in our premium SoluStab range have been specifically developed with a unique formula to provide the optimum balance of stability and solubility."
For more information, visit www.dechra.co.uk/therapy-areas/food-producing-animal/water-medication.
Dechra also offers an online tool to calculate dosage for SoluStab products at http://calculator.solustab.eu/.
Ceva says the adverts, which will air on Channel 4 and Channel 4 partner channels until 20th January, will reach 15 million people. That might prove a conservative estimate though, because the Adaptil advert on YouTube has already had over 800,000 views, whilst the Feliway advertisement has had very nearly as many.
In addition, Adaptil has partnered with The Times to support its 'Walking the Dog' podcast series hosted by radio presenter and journalist Emily Dean.
During the podcasts, Emily talks with celebrities like Noel Fitzpatrick, Jimmy Carr, Rob Bryden and Jonathan Ross as they walk their dogs. An Adaptil advert airs at the start, middle and end of each podcast.
You can hear the podcasts on itunes here: https://itunes.apple.com/gb/podcast/walking-the-dog-with-emily-dean/id1220510307
Abigail King, behaviour product manager at Ceva Animal Health said: "Our new TV advertising campaigns and podcast partnership will boost awareness of both Adaptil and Feliway throughout the festive period and into January, when changes to routine, visitors in the household and loud noises from Christmas crackers and fireworks can challenge even the most laid-back pet."
For more information, visit: www.adaptil.com or www.feliway.com.
If, as is predicted, social distancing methods need to be employed to reduce the spread of the virus, or clients find themselves having to self-isolate, video consultations may offer a way in which veterinary practices can continue to serve their clients, maintain animal welfare and, importantly, revenue.
VetHelpDirect's video consultation system, which was announced earlier this year, is still in the Beta testing phase, and the plan had been to roll out the full service in May.
Under the circumstances, however, the company has decided to offer the service to all practices immediately, free of charge for the next three months.
To use the video consultation service, you do need to subscribe to use VetHelpDirect, a service through which you can manage client reviews of your practice. That costs £38 per month, per practice and a further £16 for branch practices.
Susie Samuel, CEO of VetHelpDirect said: “The Coronavirus presents a very real business risk to veterinary practices and a health risk to staff.
"As cases increase, animal owners in quarantine will not be able to visit the vet when their animals become unwell. In these cases, veterinary practitioners will not be able to discuss an animal’s symptoms with their owner in person and could end up relying solely on telephone consultations which would most likely be conducted free of charge.
"Our video platform allows vets to collect payment for a consultation as usual, hold the consultation with the animal’s owner and if a pet needs to be seen, the owner could, in theory, drop it off at the surgery without making personal contact with the vet clinic staff."
VetHelpDirect has not yet decided precisely what the video consultation service will cost after the free period, but it is likely to be around the £20 per month mark. In addition, there is a 4.8% transaction fee.
For more information, contact Susie Samuel susie@vethelpdirect.com
COMMENTDespite the emergence of a number of online-only, limited-service veterinary video consultation providers, it seems like very few, if any independent practices are yet offering this service. There is a danger that unless they do so very soon, they will find themselves at a real disadvantage to the first movers. But there is still time; according to VetHelpDirect's research, 38% of people say they would use video consultations with their own vet but only 7% with a vet they don't know..
It strikes me that now is a very good moment to start offering clients this kind of service, because regardless of government advice, there will doubtless be some who will want to avoid a trip to the vets whilst the outbreak persists.
Mr Roger faced three charges: that he had failed to provide adequate care, failed to communicate with the owner adequately and failed to keep adequate clinical records for Honey, a Shiih Tzu dog who, it transpired, had hypergycaemia.
At the initial consultation, Mr Roger took a blood sample which showed that there was an elevated blood glucose, an elevated white blood cell count, an elevated ALT and an elevated ALP (which Mr Roger took to be indicative of liver damage secondary to infection).
Mr Roger prescribed a cholagogue (ursodeoxycholic acid), an antibiotic (Synulox) and a diuretic (Frusemide).
In its findings of fact, the Committee found it likely that Mr Roger would have realised that Honey had a potential diabetes mellitus diagnosis with an elevated blood glucose of 28.
However, Mr Roger explained that he had believed the elevated blood glucose was due to the stress Honey had undergone in taking the blood samples.
The Committee therefore accepted that Mr Roger’s actions did not indicate a complete failure by him to notice the elevated blood glucose because he had explained he believed at the time it was due to stress.
Honey’s owner took her back to the veterinary practice that Mr Roger worked at three days later.
A different veterinary surgeon examined Honey and flagged that her blood sugar was high and that her liver was damaged.
She was taken to an alternative veterinary practice for follow-up but died later that day.
Mr Roger admitted failing to ask Honey’s owner if there was a history of diabetes mellitus, failing to take repeat blood glucose tests or carry out urine analysis or carry out additional blood tests, failing to communicate adequately with Honey’s owner about the significance of the hyperglycaemia and the options for investigation/management and failing to keep adequate clinical records in regard to Honey’s blood glucose levels.
The Committee found the admitted facts proved.
The evidence presented to the Committee included the clinical notes taken during Honey’s consultations, emails sent from Honey’s owner to the RCVS outlining the complaint, and evidence from experts in small animal veterinary practice.
Although the Committee found some matters not proved, it did find proved that Mr Roger had failed to recognise and/or pay adequate regard to Honey’s elevated blood glucose levels, had failed to manage Honey’s hyperglycaemia either by treating it or by documenting an appropriate plan to do so and had failed to communicate adequately with Honey’s owner about the significance of her elevated glucose and the reason for it.
Having reached its decision in relation to the facts, the Committee went on to consider whether the facts it had found proved either individually or cumulatively amounted to serious professional misconduct.
Judith Way, Chairing the Committee and speaking on its behalf said: “The Committee found that the charges and particulars it had found proved did not amount to disgraceful conduct in a professional respect either individually or cumulatively.
"In its judgment, the conduct found proved fell short of the standard to be expected of a reasonably competent veterinary surgeon but not far short of the standard which is expected of the reasonably competent veterinary surgeon.”
As a result of the Committee finding that Mr Roger was not guilty of serious professional misconduct on any of the proven charges, either individually or in any combination, the hearing did not proceed further.
On 23rd March, the Government demanded that the majority of public-facing businesses close their doors. Veterinary surgeries, however, have been exempted and are allowed to remain open.
However, the number of clients seen face-to-face should be kept to an absolute minimum and veterinary teams must insist on strict social distancing measures at all times.
In addition, the RCVS/BVA say that:
The College has updated its FAQs for veterinary professionals, which can be found here: https://www.rcvs.org.uk/setting-standards/advice-and-guidance/coronavirus-covid-19/
The BVA is now developing some further guidance to provide examples of what constitutes routine, urgent and emergency care.
The new rules will make it illegal to sell puppies younger than eight weeks and require anyone breeding and selling three or more litters of puppies a year to apply for a formal licence.
Those needing a licence, including online sellers, will also be required to display their permit in any advertising, and to give owners information about the five welfare needs that owners must meet under the Animal Welfare Act.
The penalty for breaking the new law will be an unlimited fine and/or up to six months in prison.
The plans also cover how pet shops, boarding houses and riding stables are licensed, introducing a single 'animal activities licence' to improve the process and make enforcement easier.
Environment Secretary Andrea Leadsom said: "Everyone who owns a pet or is looking to introduce one into their life will want to know that the animal has had the very best start to life. Yet for thousands of puppies born each year to irresponsible breeders, from smaller operations to larger puppy farms, their first weeks are spent in cramped and squalid conditions without the care and attention they need. That is why we are cracking down on the worst offenders by strengthening the dog breeding licence and giving councils the power they need to take action.
With more and more pet sales now taking place on the internet, it’s right that this market is subject to the same strict licensing criteria as other breeders and pet shops so that consumers are not misled. The plans announced today will help people choosing new family pets to be confident the animals have been properly bred and cared for from birth and are ready to move safely to their new homes.
Gudrun Ravetz, President of the British Veterinary Association, said: "This is a significant step in the right direction to improve the welfare of puppies and dogs in the UK, an issue our members are extremely concerned about as increasing numbers of poorly bred puppies are brought into veterinary practices.
"Poorly bred and badly socialised puppies cause terrible health and welfare problems for dogs so it is right that Defra has made irresponsible dog breeding a priority. We particularly welcome the move to make the sale of a puppy under eight weeks illegal, the reduction in the number of litters bred requiring a formal breeder’s licence, and the moves towards a single animal activities licence. In the future we would also like to see that anyone breeding from a dog should be required to register with their local authority.
"For these new measures to work in practice local authorities must have the necessary resources and support to fully enforce the legislation, supported by local veterinary expertise.
"We hope the new legislation will encourage owners to stop and think about where they’re getting their puppies from to tackle irresponsible breeding both at home and abroad. Prospective owners should do their homework and always use the puppy contract and information pack to make sure they ask breeders the right questions for a happy, healthy puppy."
The Kennel Club and Dogs Trust have welcomed the announcement.
Dogs Trust Veterinary Director, Paula Boyden said: "As the UK’s largest dog welfare charity, Dogs Trust welcomes the Government’s review of animal establishments licensing in England and the range of measures it sets out.
"We are particularly pleased that it will be illegal to sell a puppy below the age of 8 weeks and that there will be tighter licensing rules which will require sellers of pets to display their licence when advertising. We also applaud the move towards a risk based single licensing system which will incorporate those breeders that have gained UKAS approval rather than exempting them.
We believe that Local Authority Inspectors need support to enforce these tighter licensing rules. As such, moves to mandate the use of Model Conditions and for inspectors to be offered training and standards to be set is most welcome."
With fewer than 72 female Suffolk Punches remaining in the UK and fewer than 300 in the world, every female born is vital to the survival of this endangered British horse.
In 2019 Tullis Matson, owner and managing director of Stallion AI Services, saw an opportunity to use a new technological advancement in the sex sorting of equine semen to provide a lifeline to Britain’s critically endangered rare and native horses.
Tullis said: “To be able to use our reproduction expertise in this way, to help preserve an irreplaceable part of our magnificent heavy horse heritage is something we have been working towards for many years. The challenges have been great and many, but watching the birth of this beautiful, healthy filly foal was a truly magical experience."
The sex sorting project uses specialist equipment to sex sort the semen prior to insemination based on the difference in DNA content between X and Y bearing spermatozoa.
Ruby, the Suffolk Punch mare and Holbeach Iggy, the Suffolk stallion were selected and matched based on their genetics as part of a project between The Rare Breed Survival Trust and Nottingham Trent University that uses pedigree information to enable the breeding of small populations in a way that minimises the risk of inbreeding and genetic decline.
Christopher Price, Chief Executive of the Rare Breed Survival Trust, said: “This is tremendous news for anyone concerned with the conservation of our native equines. The most effective way of increasing the population size of this very rare breed is by increasing the number of fillies being born.
“The project demonstrates the viability of using new techniques for selecting female foals in order to increase the breeding population much more rapidly than could be achieved through relying on traditional methods. We hope it will prove to be a model for more projects in the future.”
The website has been redesigned to help pet owners improve their understanding of the disease and support their commitment to treating their pet, thus improving the survival rates of diabetic pets.
The site includes videos which show how to give insulin injections to dogs and cats. There are also links to the Pet Diabetes Tracker App, which helps owners of diabetic pets monitor and record their pets’ progress. There are also tools to help pet owners build glucose curves they can share with their veterinary practice, and FAQs that will answer their main concerns.
The company is also offering additional support to help veterinary practices raise awareness of pet diabetes in the form of staff training and a Pet Diabetes Month Resource Pack.
Caroline Darouj, Senior Product Manager at MSD Animal Health said: "Pet diabetes continues to rise in the UK1,2 due to the growing prevalance of obesity in our pets. Research has shown that up to 20% of diabetic pets die, or are euthanised, within a year of diagnosis3. Many of these early deaths however, are avoidable and effective management can result in good outcomes in most pets. A diabetes diagnosis should not be a life sentence for our pets.
"This campaign and new website will make a big difference, giving practices the tools to engage pet owners, provide treatments plans and explain effective disease management. Diabetes is a disease with many elements that can feel overwhelming for pet owners so it’s vital that all veterinary practice team members have the right resources to be able to advise and support them so their pets can lead long and happy lives."
To sign up for a pack practices should go to www.msd-animal-health-hub.co.uk/PDM
References
Established over 100 years ago, Alfreton Park Veterinary Hospital is based in a purpose-built clinic; one of four International Society of Feline Medicine (ISFM) recognised Cat Friendly Practices in Derbyshire.
Dr Nick Pine MA VetMB MRCVS has been at Alfreton Park since 1999 and has become a Medivet Branch Partner following the acquisition, together with his colleague Dr Matt Ingram CertSAS MRCVS. He said: "We are excited about joining the Medivet Partnership. It will help us to continue to develop what is an already successful, trusted and highly respected local practice and enable us to offer even more opportunities for our people."
Medivet Chief Executive Officer Dr Arnold Levy, said: "Alfreton Park is an impressive practice with a great team and we are delighted to welcome them to Medivet. Our model is focused on adding value to every practice that joins our partnership, and we look forward to working with Nick and Matt to build an even brighter future for the practice, its clients and patients."
The statistic came to light as a result of Ceva's Mercury Challenge1, in which veterinary practices from around Europe took blood pressure readings from over 10,000 cats over seven years old, 4000 of which were from the UK.
The Challenge results, which were recently presented at Ceva Cat Expertise 2021 by the international feline medicine specialist, Dr Andy Sparkes, showed that more than 40% of cats enrolled in the Mercury Challenge were hypertensive, with a blood pressure about 30% higher than the blood pressure value found in healthy cats.
Ceva says this high percentage suggests that feline hypertension may be even more common than suspected, especially in the ageing cat population, with the mean age of hypertensive cats found to be 13 years old in the Challenge.
The study also found that up to one in three cats had both hypertension and chronic kidney disease (CKD). Feline hypertension is also associated with hyperthyroidism.
Jodie Tanner, veterinary surgeon at Lime Tree Vets in Staffordshire who participated in the Mercury Challenge said: “We were surprised by how many of the cats whose blood pressure we measured as part of the Mercury Challenge were actually hypertensive and were taken aback at the number of hypertensive cats which lacked clinical signs or target organ damage.
"These hypertensive cats would have previously gone undetected prior to us screening our older patients and they would probably have only presented when they had advanced target organ damage, such as blindness.
“Measuring blood pressure in cats is now incorporated into our bespoke preventative health care plan – The Pet Plus Membership – and our ‘Gold Plan’ is tailored to our patients over eight years of age.
"Included in the Gold Plan are twice yearly blood pressure checks, so we can pick up hypertension cases as early as possible, and the plan also includes twice yearly urine screens and yearly blood screens to pick up other common diseases seen in older cats such as hyperthyroidism and CKD.”
Ceva has a range of resources available to support veterinary practices, including those that want to set up vet nurse blood pressure clinics. There's a digital hypertension tool kit available by registering at www.easethepressure.co.uk, where you will also find information on the Hypertension CPD Hub, an Ease the Pressure pack containing resources to support vet practices, owner communications materials and information about Ceva’s online Hypertension Ambassador CPD course. A vet practice social media pack is also available.
For further information, visit www.easethepressure.co.uk or contact your local Ceva territory manager.
Reference
Using practices developed for human healthcare measurement, NewMetrica developed VetMetrica, which the company says can measure how an animal “feels” about its circumstances from its individual perspective.
Jim Brick, Vice President Commercial Development and Lifecycle and Innovation at Zoetis said: "This novel approach supports a significant shift in veterinary care and animal welfare more generally towards the attainment of good or excellent quality of life in companion animals.
"The benefits of NewMetrica’s digital instruments have been validated through scientific publications and the FDA, and the EMA has confirmed the algorithms that produce the results.”
Jamie Brannan, President International Operations, Zoetis added: "We expect NewMetrica’s tools and algorithms to support earlier detection and treatment of diseases as we gain more insight into the quality of life of our pets and be an important element of future product development.
“NewMetrica’s instruments will give us scientifically validated results for alleviation of OA pain that veterinarians and pet owners will appreciate and value.”
https://www.newmetrica.com
Prilactone Next is replacing the spironolactone products Prilactone and Tempora, which will be discontinued.
Prilactone Next is available in three presentations of 10mg, 50mg and 100mg. It comes in easy-break, chewable tablets, designed to make it easier to give the required dose. The 10mg tablet has a two-way split for a dog between 2.5kg and 5kg, while the 50mg and 100mg tablets have a four-way patented clover-shaped design with the 50mg for dogs between 18.1kg and 25kg and 100mg for dogs between 37.6kg and 50kg.
Prilactone Next is available in boxes of three blisters of 10 tablets for the 10mg and 50mg presentations and three blisters of eight tablets for the 100mg presentation, for easy dispensing and storage in practice.
Nicola Barclay, product manager at Ceva Animal Health, said: "Prilactone Next is an improved, easy to administer spironolactone that enables owners to accurately treat their pets and will further enhance our existing cardiology range."
For further information, contact your local Ceva Animal Health territory manager.
Zenrelia is a new JAK inhibitor which Elanco says provides visible itch relief which lasts 24 hours, from the first dose.1
The company points to a head-to-head study with over 330 dogs across 25 vet clinics, in which Zenrelia was shown to get nearly 50% more itchy dogs back to normal than Apoquel (oclacitinib).1
Elanco says its once-daily dosing may also improve treatment compliance over twice-daily alternatives.
The company also says that Zenrelia has a cost benefit too, presumably meaning it's cheaper than alternatives.
Zenrelia can be given long term with commonly used medications, including vaccines, antibiotics, parasiticides and NSAIDs.
Elanco UK & Ireland General Manager Matthew Frost said: “With this treatment, we’re looking at happier dogs and their owners, and a more rewarding experience for vets.”
www.zenrelia.co.uk
I had hoped that the increasing absurdity of the reasons given for the rise might have tipped everyone off to the fact that the story was a spoof.
The idea that the College would ask its members to fund some glitzy, showy, award-winning designer headquarters along the lines of London’s City Hall? C’mon. London City Hall employs 1000 staff, whilst the Royal College employs less than 100. And let's face it, the RCVS has no record of having showy offices. On the contrary, it has managed to operate out of a sardine can now for a great many years. Have you ever been in the lift at Horseferry Road? You need to breathe in.
Or that the College had set aside £6M to recruit and pay 20 veterinary surgeons as short term contracted OVs to help in the event of a no-deal Brexit. Let’s say a flight from Delhi to London costs £500, give or take. Twenty vets. That’s £10,000 to get them here. Let's say they’re here for 6 months. That’s £299,500 per vet. You really think the College is going to ask you to pay more than a quarter of a million pounds to fly in a single vet for 6 months? Or that 20 recruits would solve the predicted OV shortage?
Lastly, the quote, supposedly from an Indian vet, but one with a name that doesn’t really sound like a name (still less an Indian one), but does sound strangely like it may be an anagram of April Fool.
There have been a small number of reports of people being really upset by this story. I guess they must have skim read, or only read the headline.
To them I want to say sorry, I genuinely didn’t mean to upset anyone.
In fact, I thought it might cause some reflection on what good value the RCVS really offers. It maintains the register and thereby your ability to practice, it runs the disciplinary process (an essential component of maintaining public trust), it oversees and sets educational standards, it awards Fellowships, Diplomas and Certificates, it runs the Practice Standards Scheme.
All that, and more for £340 per annum?
Honestly? I think it would be cheap at half the price.
Photo: Truth is that the RCVS has operated out of a sardine can for years.By Rl - Own work, CC BY-SA 3.0, Link
The study, which was led by the College's VetCompass programme, found that British bulldog ownership has increased from 0.35% of all puppies born in 2009 to 0.60% in 2013.
At the same time, the study found that British bulldogs suffer more than other breeds from a number of conditions associated with their aesthetic characteristics, including: skin fold dermatitis (7.8%), prolapsed gland of the third eyelid or 'cherry eye' (6.8%), interdigital cysts (3.7%), entropion or inward turning of the eyelid (3.6%), and corneal ulceration (3.1%).
Worse still, only 3.5% of the 1,621 British bulldogs analysed in the study were diagnosed with brachycephalic obstructive airway syndrome (BOAS), despite an earlier study reporting that 84.8% of tested Bulldogs are affected by BOAS to some extent, with 44.0% exhibiting clinically relevant disease2.
This, say the researchers, suggests owners consider breathing problems such as snoring as normal and are not therefore taking their dogs for needed check-ups.
Other findings included:
12.7% of British bulldogs suffer from ear infections, 8.8% from skin infections and 8.7% from obesity
Males are more likely than females to develop skin infection, interdigital cysts, atopic dermatitis and aggression, whereas females are more likely to develop dental disease and obesity.
The average adult bodyweight for a British bulldog is 26kg.
The average lifespan of bulldogs is 7.2 years.
The most common causes of death are heart disease (11.8%), cancer (10.9%) and brain disorder (9.1%).
The RVC says that the results of the study will support initiatives by the Kennel Club and the UK Bulldog Breed Club to improve breeding and also help owners and vets prioritise tackling the leading issues British bulldogs face.
Dr Dan O’Neill, VetCompass epidemiologist at the RVC and Chairman of the Brachycephalic Working Group, said: "The UK has seen unprecedented increases in the popularity of certain short-faced breeds over the past decade. This has led to a series of well-documented welfare issues relating to how these dogs are bred and sold for the UK pet-owning market, high levels of dumping of unwanted dogs into the UK charities and health problems that are intrinsically linked to the extreme body shape of these dogs.
"This new study gives firm evidence for the first time on the true levels of popularity and also of disease diagnosed in the wider population of bulldogs in the UK. This information can help to move the conversation on welfare from 'what are the issues' to 'how do we deal with these issues'. Reliable evidence is pivotal to good decision-making."
Dr Rowena Packer, BBSRC Research Fellow at RVC, said: "The bulldog is an iconic breed but concerns over the health problems allegedly facing these popular dogs have mounted in the past decade. It is extremely valuable to have solid data on the health problems facing this breed, confirming a number of inherent breed predispositions that need to be tackled.
This data supports current initiatives encouraging breed reform, particularly regarding health problems inherently related to their looks, and the need for selection for healthier body shapes. For example, skin fold dermatitis was common in bulldogs and is associated with the desired wrinkled face in this breed – this calls into question the justification of this and other such breed traits that put dogs at risk of potentially avoidable disease."
Steve Dean, Chairman of the Kennel Club Charitable Trust said: "The Kennel Club has put into place a number of crucial measures over the years to monitor, protect and improve bulldog health and to provide the many responsible breeders with the tools they need to do the same, but this paper highlights there is still work to be done."
The study is published open access in PLOS ONE.
References:
According to a report in the Daily Mail, Worcester vet David Denny MRCVS accidentally euthanised a Jack Russell in the presence of its owner, who believed he was giving the animal antibiotics.
Mr Denny told VetSurgeon.org that it had been the result of a dreadful misunderstanding between himself and his secretary, for which he had apologised, but that he couldn't say much more because the VDS had advised him not to talk to the media.
The dog, called Gunner, was 14 years old; old enough that alarm bells obviously didn't go off when it was presented to Mr Denny for euthanasia (or so he thought).
The story does serve as a reminder of the importance of communicating with absolute clarity, both written and oral, when performing euthanasia. In this case, the Daily Mail reports that Mr Denny asked the client: "if Gunner had had enough". Under any other circumstances, that would seem a sensitive comment to make. In this case, though, the owner thought he meant the dog had had enough of its cough.
Animalcare has launched Emdocam (meloxicam 20mg/ml), a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class for use in cattle, pigs and horses.
According to the company, Emdocam disrupts the inflammatory cascade by inhibiting prostaglandin synthesis. It is a potent and preferential inhibitor of COX-2, permitting sufficient COX-1 sparing activity. It has analgesic and anti-inflammatory effects. When administered in a single dose to cattle, it has long acting anti-endotoxic, anti-pyretic and anti-inflammatory effects for up to three days.1,2
In cattle, it is indicated for bovine respiratory disease (BRD), clinical mastitis and calf scour. Animalcare says early use of meloxicam for BRD reduces pyrexia and pain, especially in young calves and improves feed intake. Meloxicam plus an antibiotic significantly reduced the extent of lung lesions, leading to improved clinical efficacy and daily liveweight gain in comparison with animals treated with antibiotics alone, for example oxytetracycline,3 florfenicol4and tilmicosin. 5
In the case of clinical mastitis, Animalcare says that used adjunctively with an antibiotic, Emdocam helps relieve local and systemic inflammation, returns the udder to a normal condition and reduces the polymorphonuclear leucocytes (PMN) response. In a large scale, double-blinded study in New Zealand, the addition of meloxicam to antibiotic therapy resulted in lower Somatic Cell Counts and a reduced risk of culling in dairy cows with mild clinical mastitis.6
Calf scour treated with meloxicam, as a supportive therapy, can improve calf well-being and reduce morbidity. In a double-blinded, controlled study, the use of meloxicam improved daily water and feed intake, added greater average bodyweight (bw) gain and helped calves to wean earlier. 7
In horses, administered IV at 3.0ml/100kg bw, Emdocam can be used for musculo-skeletal disorders, as well as colic, resulting in reduced pain and inflammation. In a study of 18 horses comparing flunixin with meloxicam and designed to determine the effect on recovery of ischemic-injured jejunum, meloxicam was found to be a useful alternative for the post-operative treatment of colic. 8
Emdocam is also indicated in pigs for non-infectious locomotive disorders and as an adjunctive therapy with an antibiotic in puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome).
Tony Liepman from Animalcare said: "Emdocam is competitively priced whether used on its own or adjunctively with a long-acting intramuscular (IM) antibiotic, such as Florgane suspension for the treatment of BRD in calves. This, coupled with its long lasting, low volume (2.5ml/100kg bw in cattle), single dose administration, by intravenous (IV) or subcutaneous (SC) injection, makes Emdocam a highly efficacious and practical NSAID."
Emdocam is a POM-V medicine and available as 50 and 100ml multi-dose vials. Withdrawal period in cattle for meat and offal is 15 days and in pigs for meat and offal is 5 days. In horses for meat and offal it is 5 days. In Florgane [POM-V], the withdrawal period for meat and offal is 37 days in cattle and not to be used in cattle producing milk for human consumption
Cattle
A graduate of University College Dublin, Richard started out in first opinion practice after completing an internship at the University of Glasgow.
While studying medicine, Richard researched mast cell tumours in dogs, which led to an MSc in clinical Oncology. He went on to complete a PhD on mast cell tumours at the Royal Veterinary College in 2008.
Richard works with referral oncology patients and clients two days a week at LVS and currently spends the rest of his working week as an oncology consultant for IDEXX Laboratories.
From February, Richard will also be working at Southfield Veterinary Specialists in Laindon, Essex, thereby allowing him to refer oncology patients for radiation therapy at Southfields when necessary.
Richard said: "Having never been comfortable with operating myself, working with a team of this calibre and experience in a welcoming environment within central London was very attractive. It has been a very fulfilling role for me, especially as both our team and the scope of the services we can offer continue to expand.
"Given the high standard of care offered by local vets in the area, the patients referred to LVS are often very challenging. Together with our clients’ high expectations, the service is definitely not run-of-the-mill but all the more rewarding because of that.
"I’m looking forward to bringing my experience in both research and clinical spheres to LVS."
Richard’s main professional interests are mast cell tumours, novel diagnostics and immunotherapeutics, but he is experienced in all aspects of veterinary oncology and can also offer advice about internal medicine cases.
Betafuse contains 5mg/g fusidic acid and 1mg/g betamethasone gel. It is available in 15g and 30g polyfoil tubes, designed to reduce the likelihood of splitting and loss of product during use.
Richard Palmer, Global Head of Sales and Marketing at Norbrook said: "We are delighted to be bringing this new product to the market in 16 European countries including the UK and Ireland. Betafuse is particularly exciting for us as we have improved the packaging and we have extended the 'in use' shelf life to eight weeks in comparison to six weeks for the pharmaceutically equivalent pioneer.
"This continued investment in our companion animal portfolio comes on the back of our recent launch in the US of Carprofen Chewable Tablets, an anti-inflammatory also for dogs. Our £40 million multi-year investment programme which we are currently engaged in, includes a significant emphasis on new product development including investment in R&D and our facilities infrastructure."
Lizzie Barnard, UK Product Manager added: "Betafuse offers the prescribing veterinary surgeon greater choice and it complements our existing companion animal skin care portfolio which includes Marbodex, a treatment for otitis externa in dogs.
"“Product support material is available and includes a guide for dog owners on how to apply Betafuse simply and effectively. This leaflet is available by contacting your territory manager or by downloading it from our website."
For more information, visit: https://www.norbrook.com/
The study “Approach to initial management of canine generalised epileptic seizures in primary-care veterinary practices in the United Kingdom” used the Small Animal Veterinary Surveillance Network to review electronic health records equating to 3,150,713 consultations (917,373 dogs) from 224 veterinary practices2.
Five hundred and seventeen cases were included. Dogs older than 6 years were excluded.
Of 321 dogs presented for a single seizure, seven (2.1%) were prescribed AEDs, which is in accordance with International Veterinary Epilepsy Task Force recommendations.
20% of the dogs in this group which had at least a 6-month follow-up, 20% did not have subsequent seizures recorded.
However, of 86 dogs which had suffered a seizure cluster at first presentation, only 38 (44%) were prescribe an AED, despite the task force recommendation that long term treatment in dogs with idiopathic epilepsy should be started immediately in the case of 2 or more seizures within 6 months, status epilepticus or a seizure cluster, severe post-ictal signs, or a deteriorating epileptic presentation.
Imepitoin was frequently selected in the treatment of cluster seizures despite no authorisation for this purpose.
Nicola Di Girolamo, Editor of JSAP said: “Studies like this one are instrumental to understand how primary care clinicians comply with current recommendations.
"Additional efforts may be required to fully adhere to the International Veterinary Epilepsy Task Force recommendations; being aware of these gaps is the first step towards improvement.”
Poulvac CVI + HVT Marek’s vaccine provides the combination of the Rispens CVI strain and the HVT strain.
Zoetis says this combination of serotypes has long been recognised for providing strong, reliable protection against the disease, effective even against the very virulent pathotype of the virus.
John Kenyon, Zoetis National Veterinary Manager for Poultry said: "Marek’s disease remains a major problem for the poultry industry.
"To increase protection, it is a good idea to combine the CVI and HVT vaccine strains, and the new supplies of our vaccine help to make this more feasible.
“Currently in some longer-lived broilers and backyard laying hens a vaccine composed of just a single serotype is used, but it is advantageous to use a combination of serotypes to boost immunity further.”
Marek’s vaccination with Poulvac CVI + HVT can be performed in the hatchery at day of age via subcutaneous or intramuscular injection.
The Zoetis vaccine is supported with a range of services, including hatchery and vaccine audits, vaccine training and technical assistance.
Duncan makes three requests of the UK Government:
The first is to make changes to encourage more overseas vets, and specifically the return of EU vets.
The second is to increase funding for UK universities to provide veterinary courses.
The final request is to update the regulatory framework to enable veterinary nurses to expand their role.
Full article: https://ivcevidensia.co.uk/News/duncan-phillips-time-to-overhaul-vet-support
The Apple iPad made its UK debut last week. I queued outside the Apple shop for over 15 minutes (well, it was Salisbury, not Regent Street) on launch day to get my hands on one of the first and review it for VetSurgeon members.
For those that don't have the time for long-winded reviews, I'll come straight to the point: buy one, you won't regret it. Even if you get home and decide you have no use for a tablet computer, you could probably put it on ebay and turn a small profit. But you won't. You'll just keep finding more reasons why the iPad is an indispensable piece of kit.
I won't dwell on the technical specifications of the thing. All you really need to know is that it's a touchscreen tablet computer about the size of a small hardback, though it weighs a little more. I don't know (or care) what sort of chip it contains. Whatever it is, it's more than capable of handling the tasks the iPad is designed to do, effortlessly.
So why is the iPad a 'must have'? Because it transforms the experience of browsing the Internet, reading email etc. from being a bit of a hassle, to being as simple and quick as, er, picking up and opening a book. I think the best way to illustrate my point is to describe the uses I've found for it in the first 4 days of ownership:
BrowsingI wanted to know what's on locally for children this weekend. Normally I'd have to go and power up the computer upstairs. Not anymore. Now I just pick the iPad up off the kitchen table. It wakes instantaneously, and the browser opens at the press of a button. Incidentally, once I'd found the Sherborne Fair, it was only another couple of clicks before it was displayed on the built-in map, along with an estimated time to get there. In my case, it also makes my job easier - I can dip into the VetSurgeon and VetNurse forums much more easily when away from my desk (something I intend to be more of, from now on).
EmailNot much to say, except that once again, it's a pleasure to be able to check my email at the press of a button, rather than having to go upstairs and power up my desktop, or wait whilst my wife's interminably slow laptop gets its act together. No, the touch screen keyboard is not quite as well suited to the task as a normal keyboard. Having said that, I typed half this article on my iPad last night at very nearly the same two-handed speed as I would have on my desktop.
Read the newspaperThe Times is now available on the iPad for £9.99 per month. You just press the download button any time after 7:00am, and a few minutes later it appears on the screen. If you fall into the camp that says: 'it'll-never-catch-on-....-nothing'll-replace-the-feel-of-a-book-or-a-newspaper', I wouldn't have argued with you a week ago. Now I would. The iPad version is beautifully intuitive, and a pleasure to read. Despite a few grumbles (where is The Sunday Times?), I'll be cancelling my print subscription.
PhotographsThis is really the first viable alternative to the traditional print photograph album. And it's not just an alternative, it's a far superior way of storing and retrieving photographs. The iPad's high quality display means your pictures really leap off the screen. Its portability and ease of access mean that you might actually look at your photos and share them with others from time-to-time, rather than leaving them to gather dust in a box, or sit in an unvisited folder on your computer. I'm digitising 20 year's worth of photographs for this reason.
Other uses and appsThe list of software applications for the iPad is growing every day. Meantime, any app designed for the iPhone will also run on the iPad, though they don't make full use of the big screen. There are thousands of rather pointless apps, seemingly designed not to meet a need nobody knew they had. But amongst the rubbish, there are some genuinely useful apps out there:
A couple of minor irritations about the iPad. Currently it doesn't support the rich editing feature used by default when you post to the VetSurgeon forums, or elsewhere on the site. Fortunately, there's a quick workaround, which is to visit your VetSurgeon profile (My Account > Edit My Profile > Display Options tab) and set the Content Editor to 'Plain text'. Also, very occasionally the iPad freezes, at which point you have to press the On/Off and Home buttons together for six seconds to reset. Doubtless both these will be fixed in the next software update, due in the next month or two, I think.
The 'twitterati' has bemoaned the iPad's lack of hardware features and flexibility. There's nowhere to insert a DVD. No camera. No USB port. No card reader. But that rather misses the point. The iPad isn't a replacement for a desktop or laptop unless the only things you use a computer for are browsing and email. Anyone who wants to store and edit video, edit photographs, or create anything other than fairly basic documents or spreadsheets, still needs a bigger machine with USB ports and DVD drives galore. What the iPad does is free you from having to browse electronic media at a desk. And it does so in such user-friendly way that I'll be ordering one for my Mum (aged 62) and my grandmother (aged 92).
There are six models available. Three memory sizes: 16GB, 32GB and 64GB with either wi-fi Internet access, or wi-fi plus 3G mobile phone access. Prices from £429 to about £700 (to which you'll need to add the cost of a protective wallet). I plumped for the 64GB memory (probably overkill), wi-fi only model, on the basis that there are enough BT Openzone wi-fi hotspots now to mean I'll never be far from one.
I'm not normally one for hyperbole. But in this case, I'll forgive Mr. Jobs calling the iPad 'a magical and revolutionary product'.
It is.
Researchers studied 840 patients with breast, prostate, lung or colorectal cancer. 280 patients that had received only alternative medicine were matched to 560 control patients who chose conventional cancer therapy.
Overall, cancer patients who used alternative medicine were 2.5 times more likely to die within a 5 year period than those who chose conventional cancer therapy.
However, people with breast cancer were 5.7 times more likely to die in the same period if they used alternative medicine rather than conventional medicine.
This evidence flies in the face of the British Association of Veterinary Homeopathic Veterinary Surgeons' claim that homeopathy cures cancer.
But more importantly, one of the main reasons why practitioners in both human and veterinary medicine so often acquiesce to their patients' use of alternative medicine is because of the perception that they do no harm. After all, homeopathy is only water, right?
This study provides perhaps the first evidence that the reverse may be true. That if you do not actively deter clients from using discredited forms of alternative medicine, you may be allowing them to sentence themselves, or rather their dog, to an early death.
Salmoporc gives protection against Salmonella Typhimurium and its monophasic variants. It is administered orally to piglets and through subcutaneous injection in sows.
According to the company, Salmoporc is the only live, attenuated salmonella vaccine licensed for pigs in the UK and Ireland.
Ceva says salmonella in UK and Irish herds is the highest in the EU, with a prevalence of 19.5% and 17.5% respectively. It is particularly difficult to control in outdoor herds since the bacteria can survive in soil for a year, even longer in dried dung and has been detected in fields two years after being vacated by pigs.
Outdoor bred, or reared, pigmeat accounts for 12% of retail sales and the majority of this is processed.
Dr Rike Schmelz from Ceva said: "Salmonella is an increasing problem on pig farms and the bacteria are transmitted through breeding pyramids which eventually supply finishing pigs. Clinical cases of diarrhoea often occur after weaning and tend to be treated with antibiotics."
Rike added: "The monophasic variant of S. Typhimurium is already multi-drug resistant and vaccinating pigs can help farmers to substantially reduce their use of expensive antibiotics. In addition, with the removal of zinc oxide at therapeutic levels from the feed in mid-2022, salmonella and other enteric diseases are likely to become more apparent."
Ceva says that by immunising their pigs against S. Typhimurium, farmers will gain an economic benefit from lowered mortality and improved daily liveweight gain (DLWG) among their pigs.
In independent trials at the University of Ghent in Belgium, between three and 29 weeks, vaccinated piglets from three herds gained between 30g and 39g, significantly more per day than unvaccinated controls.
Trials in Germany have shown that, with vaccination of sows and gilts at the top of the breeding pyramid, combined with a competent hygiene programme, it is possible to eliminate salmonella from the supply chain.